EGFR and lung carcinoma: For example, the use of small molecule inhibitors in the treatment of epidermal growth factor receptor (EGFR) mutation positive lung cancers has lead to improved survival rates.38,39 The improved prognosis conferred by the advances in cancer-specific treatment is something that generalised scoring systems fail to account for.